Dr. Frances Herbert, M.D

NPI: 1013005982
Total Payments
$110,457
2024 Payments
$50.87
Companies
7
Transactions
31

Payment Breakdown by Category

Research$108,828 (98.5%)
Travel$1,237 (1.1%)
Food & Beverage$391.24 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $108,828 24 98.5%
Travel and Lodging $1,237 2 1.1%
Food and Beverage $391.24 5 0.4%

Payments by Type

Research
$108,828
24 transactions
General
$1,628
7 transactions

Top Paying Companies

Company Total Records Latest Year
TARO PHARMACEUTICALS USA, INC. $80,559 9 $0 (2017)
Bausch Health US, LLC $27,322 4 $0 (2018)
Roche Products Limited $1,536 3 $0 (2017)
AbbVie, Inc. $947.76 11 $0 (2019)
Myriad Genetic Laboratories, Inc. $41.11 2 $0 (2023)
Genentech USA, Inc. $36.94 1 $0 (2024)
Hologic Sales and Service, LLC $13.93 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $50.87 2 Genentech USA, Inc. ($36.94)
2023 $41.11 2 Myriad Genetic Laboratories, Inc. ($41.11)
2019 $947.76 11 AbbVie, Inc. ($947.76)
2018 $27,322 4 Bausch Health US, LLC ($27,322)
2017 $82,095 12 TARO PHARMACEUTICALS USA, INC. ($80,559)

All Payment Transactions

31 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
01/25/2024 Hologic Sales and Service, LLC Localizer (Device) Food and Beverage In-kind items and services $13.93 General
Category: Breast and Skeletal Health
01/18/2024 Genentech USA, Inc. Phesgo (Biological) Food and Beverage In-kind items and services $36.94 General
Category: BioOncology
10/11/2023 Myriad Genetic Laboratories, Inc. MYRISK (Device) Food and Beverage In-kind items and services $27.41 General
Category: ONCOLOGY
10/11/2023 Myriad Genetic Laboratories, Inc. MYRISK (Device) Food and Beverage In-kind items and services $13.70 General
Category: ONCOLOGY
07/17/2019 AbbVie, Inc. Androgel (Drug) In-kind items and services $34.22 Research
Study: M16-100 • Category: Endocrinology
07/17/2019 AbbVie, Inc. Androgel (Drug) In-kind items and services $25.00 Research
Study: M16-100 • Category: Endocrinology
07/17/2019 AbbVie, Inc. Androgel (Drug) In-kind items and services $7.14 Research
Study: M16-100 • Category: Endocrinology
04/05/2019 AbbVie, Inc. Androgel (Drug) In-kind items and services $335.96 Research
Study: M16-100 • Category: Endocrinology
04/05/2019 AbbVie, Inc. Androgel (Drug) In-kind items and services $64.00 Research
Study: M16-100 • Category: Endocrinology
04/05/2019 AbbVie, Inc. Androgel (Drug) In-kind items and services $58.57 Research
Study: M16-100 • Category: Endocrinology
04/05/2019 AbbVie, Inc. Androgel (Drug) In-kind items and services $36.06 Research
Study: M16-100 • Category: Endocrinology
04/05/2019 AbbVie, Inc. Androgel (Drug) In-kind items and services $18.86 Research
Study: M16-100 • Category: Endocrinology
04/05/2019 AbbVie, Inc. Androgel (Drug) In-kind items and services $18.75 Research
Study: M16-100 • Category: Endocrinology
04/04/2019 AbbVie, Inc. Androgel (Drug) In-kind items and services $204.06 Research
Study: M16-100 • Category: Endocrinology
04/04/2019 AbbVie, Inc. Androgel (Drug) In-kind items and services $145.14 Research
Study: M16-100 • Category: Endocrinology
07/31/2018 Bausch Health US, LLC Cash or cash equivalent $6,393.75 Research
Study: A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-123 LOTION AND IDP-123 VEHICLE LOTION IN THE TREATMENT OF ACNE VULGARIS
05/30/2018 Bausch Health US, LLC Cash or cash equivalent $4,543.75 Research
Study: A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-123 LOTION AND IDP-123 VEHICLE LOTION IN THE TREATMENT OF ACNE VULGARIS
05/14/2018 Bausch Health US, LLC Cash or cash equivalent $12,096.25 Research
Study: A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-123 LOTION AND IDP-123 VEHICLE LOTION IN THE TREATMENT OF ACNE VULGARIS
04/05/2018 Bausch Health US, LLC Cash or cash equivalent $4,287.75 Research
Study: A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-123 LOTION AND IDP-123 VEHICLE LOTION IN THE TREATMENT OF ACNE VULGARIS
11/13/2017 TARO PHARMACEUTICALS USA, INC. Topicort Spray 0.25% (Drug) Cash or cash equivalent $7,700.00 Research
Study: TaroLCNZ 1618 • Category: Dermatology
09/28/2017 Roche Products Limited Xolair (Biological) Travel and Lodging In-kind items and services $1,003.46 General
Category: Immunology
09/28/2017 Roche Products Limited Xolair (Biological) Food and Beverage In-kind items and services $299.26 General
Category: Immunology
09/28/2017 Roche Products Limited Xolair (Biological) Travel and Lodging In-kind items and services $233.63 General
Category: Immunology
09/20/2017 TARO PHARMACEUTICALS USA, INC. Topicort Spray 0.25% (Drug) Cash or cash equivalent $1,800.00 Research
Study: TaroLCNZ 1618 • Category: Dermatology
08/20/2017 TARO PHARMACEUTICALS USA, INC. Topicort Spray 0.25% (Drug) Cash or cash equivalent $9,720.00 Research
Study: TaroLCNZ 1618 • Category: Dermatology

Research Studies & Clinical Trials

Study Name Company Amount Records
TaroLCNZ 1618 TARO PHARMACEUTICALS USA, INC. $80,559 9
A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-123 LOTION AND IDP-123 VEHICLE LOTION IN THE TREATMENT OF ACNE VULGARIS Bausch Health US, LLC $27,322 4
M16-100 AbbVie, Inc. $947.76 11

About Dr. Frances Herbert, M.D

Dr. Frances Herbert, M.D is a Specialist healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013005982.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frances Herbert, M.D has received a total of $110,457 in payments from pharmaceutical and medical device companies, with $50.87 received in 2024. These payments were reported across 31 transactions from 7 companies. The most common payment nature is "" ($108,828).

Practice Information

  • Specialty Specialist
  • Other Specialties Urology
  • Location Plano, TX
  • Active Since 10/10/2006
  • Last Updated 04/17/2012
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1013005982

Products in Payments

  • Topicort Spray 0.25% (Drug) $80,559
  • Xolair (Biological) $1,536
  • Androgel (Drug) $947.76
  • MYRISK (Device) $41.11
  • Phesgo (Biological) $36.94
  • Localizer (Device) $13.93

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Plano